| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 06/21/2001 | WO2000040275A3 The preparation and use of radium-223 to target calcified tissues for pain palliation, bone cancer therapy, and bone surface conditioning |
| 06/21/2001 | US20010004639 Process for preparing arylacetylaminothiazoles |
| 06/21/2001 | DE19961182A1 Galactomannan-Oligosaccharide und Verfahren zu deren Herstellung sowie deren Verwendung Galactomannan oligosaccharides and processes for their preparation and their use |
| 06/21/2001 | CA2397601A1 Novel processes for making- and a new crystalline form of- leflunomide |
| 06/21/2001 | CA2395486A1 Saccharin derivatives as orally active elastase inhibitors |
| 06/21/2001 | CA2394654A1 Proton pump inhibitors |
| 06/21/2001 | CA2394646A1 Novel purines |
| 06/21/2001 | CA2394640A1 Galactomannan-oligosaccharides and methods for the production and use thereof |
| 06/21/2001 | CA2394570A1 N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses |
| 06/21/2001 | CA2394552A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]carboxamideinhibitors of cyclin dependent kinases |
| 06/21/2001 | CA2394544A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| 06/21/2001 | CA2394538A1 Aminothiazole inhibitors of cyclin dependent kinases |
| 06/21/2001 | CA2394536A1 Tnfr/opg-like molecules and uses thereof |
| 06/21/2001 | CA2394504A1 Fragments and antagonists of heat shock protein 60 |
| 06/21/2001 | CA2394431A1 Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists |
| 06/21/2001 | CA2394416A1 Composition in the form of a gel for receiving an active ingredient in a solution or suspension, especially for application on a mucous membrane and method of production thereof |
| 06/21/2001 | CA2394167A1 Compositions and methods for inhibiting endothelial cell proliferation |
| 06/21/2001 | CA2394160A1 Human oxidoreductase proteins |
| 06/21/2001 | CA2394077A1 System and method for extended delivery of a therapeutic agent with its receptor loading dose |
| 06/21/2001 | CA2393972A1 Cyclopenteneone derivatives |
| 06/21/2001 | CA2393808A1 Anti-cancer synthetic oligonucleotides |
| 06/21/2001 | CA2393762A1 Hydroxide-releasing agents as skin permeation enhancers |
| 06/21/2001 | CA2393672A1 Selective neurokinin antagonists |
| 06/21/2001 | CA2392992A1 Imidazopyrimidinyl and imidazopyridinyl derivatives |
| 06/21/2001 | CA2392894A1 New p2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases |
| 06/21/2001 | CA2390689A1 Human lyases and associated proteins |
| 06/20/2001 | EP1108046A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation |
| 06/20/2001 | EP1108039A2 Elongase genes and uses thereof |
| 06/20/2001 | EP1108029A1 Kunitz domain polypeptide zkun6 |
| 06/20/2001 | EP1108019A2 Protein transport-associated molecules |
| 06/20/2001 | EP1108016A2 Mapkap kinase 2-inhibitors and the use thereof in anti-inflammatory therapy |
| 06/20/2001 | EP1107978A1 Secreted proteins and polynucleotides encoding them |
| 06/20/2001 | EP1107973A1 Novel compounds |
| 06/20/2001 | EP1107971A1 Porphyrin derivatives, their use in photodynamic therapy and medical devices containing them |
| 06/20/2001 | EP1107965A1 Pyridyl ethers and thioethers as ligands for nicotinic acetylcholine receptor and its therapeutic application |
| 06/20/2001 | EP1107959A2 Quinazoline derivatives as medicaments |
| 06/20/2001 | EP1107957A1 Pyrimidine compounds |
| 06/20/2001 | EP1107954A1 2-OXO-$i(2H)-QUINOLINE DERIVATIVES |
| 06/20/2001 | EP1107953A1 Hydroxamic acid derivatives as proteinase inhibitors |
| 06/20/2001 | EP1107795A2 Methods and compositions for the prevention or treatment of cancer |
| 06/20/2001 | EP1107788A1 Scrp-5: secreted cysteine rich protein-5 |
| 06/20/2001 | EP1107780A2 Selective treatment of endothelial somatostatin receptors |
| 06/20/2001 | EP1107779A2 Medicaments for manipulating t-cell immune response |
| 06/20/2001 | EP1107767A2 Use of selenium for treating patients suffering from systemic inflammatory response syndrome (sirs), and composition for implementing said treatment |
| 06/20/2001 | EP1107758A2 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase |
| 06/20/2001 | EP1107755A1 N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders |
| 06/20/2001 | EP1107744A2 Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of nk-1 receptor antagonists for the treatment of chronic fatigue syndrome |
| 06/20/2001 | EP1107741A1 Orally administered controlled drug delivery system providing temporal and spatial control |
| 06/20/2001 | EP1107738A1 Novel pharmaceutical salt form |
| 06/20/2001 | EP1107731A1 Synthetic tear fluid |
| 06/20/2001 | EP0984961B1 Novel pyridine derivatives and pharmaceutical compositions containing them |
| 06/20/2001 | EP0796260B1 Rapamycin 42-oximes and hydroxylamines |
| 06/20/2001 | EP0733043B1 Tricyclic derivatives and their use in pharmaceuticals |
| 06/20/2001 | EP0618962B1 Thymidine phosphorylase for use in the modulation of cellular proliferation or chemotaxis |
| 06/20/2001 | CN1300285A Oxyiminoalkanoic acid derivatives |
| 06/20/2001 | CN1300282A Pyrazole derivatives as P-38 MAP kinase inhibitors |
| 06/20/2001 | CN1300278A Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 06/20/2001 | CN1299679A Arthralgia treating prescription |
| 06/20/2001 | CN1299670A Plaster and its preparation |
| 06/20/2001 | CN1299658A Medicine powder for eliminating tumor and cancer |
| 06/20/2001 | CN1067385C Novel substituted piperidines useful for the treatment of allergic diseases |
| 06/20/2001 | CN1067378C N,N-diethyl-8,8-dipropyl-2-azaspiro(4.5)decane-2-propananine dimaleate |
| 06/20/2001 | CN1067255C Fragrant drug steam |
| 06/19/2001 | US6248903 Process for the preparation of methyl (2s)-2-[(3r)-3-(n-{tert-butyloxycarbonyl 9-amino)-2-oxopyrrolidin-1-yl]propionate |
| 06/19/2001 | US6248901 Heterocyclic vinyl ethers |
| 06/19/2001 | US6248787 Reducing cachexia |
| 06/19/2001 | US6248783 Cyclopentane 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivatives as therapeutic agents |
| 06/19/2001 | US6248765 Imidazole derivatives as histamine receptor H3 (ANT) agonists |
| 06/19/2001 | US6248755 Antiinflammatory agents; antiallergens; autoimmune diseases |
| 06/19/2001 | US6248753 Bicyclic compounds |
| 06/19/2001 | US6248745 Mixture comprising a cyclooxygenase-2 (cox-2) inhibitor and a 1,2-dihydro-4-aminoquinazoline derivative inhibitor of induced nitric oxide synthase (inos); non-steroidal antiinflammatory agents |
| 06/19/2001 | US6248738 Isoquinolines as urokinase inhibitors |
| 06/19/2001 | US6248737 1-phenyl-3-dimethylaminopropane compounds with a pharmacological effects |
| 06/19/2001 | US6248713 Cell adhesion inhibitors |
| 06/19/2001 | US6248594 Kinesin-like motor protein |
| 06/19/2001 | US6248368 Administering magnesium salt |
| 06/19/2001 | US6248367 Bovine excretion extracts having anticancer and anti-inflammatory activity and process for preparing the same |
| 06/19/2001 | US6248365 Use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura |
| 06/19/2001 | US6248363 Improved delivery of hydrophilic or hydrophobic pharmaceutical active ingredients, such as drugs, nutraceuticals, cosmeceuticals and diagnostic agents |
| 06/19/2001 | US6248350 Antiinflammatory analgesic patch |
| 06/19/2001 | US6248343 Mixture of triclosan and plant extract |
| 06/19/2001 | US6248308 Methods of using norastemizole in combination with leukotriene inhibitors to treat or prevent asthma |
| 06/19/2001 | CA2191129C Drugs containing metronidazole or a synergistic mixture of metronidazole and clindamycin |
| 06/19/2001 | CA1341256C Combination of pyrimidine derivatives and non steroidal anti-inflammatory agents to induce and stimulate hair growth and reduce hair loss |
| 06/14/2001 | WO2001042484A1 Il-6 like polynucleotide |
| 06/14/2001 | WO2001042471A2 Polypeptides and polynucleotides encoding same |
| 06/14/2001 | WO2001042462A2 Phospholipase a2 inhibitory peptides from python reticulatus |
| 06/14/2001 | WO2001042368A1 Substituted phthalocyanines and their precursors |
| 06/14/2001 | WO2001042305A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | WO2001042288A2 G-protein coupled receptors |
| 06/14/2001 | WO2001042285A2 Extracellular matrix and cell adhesion proteins as well as genes encoding them |
| 06/14/2001 | WO2001042282A1 Depsipeptide and congeners thereof for use as immunosuppressants |
| 06/14/2001 | WO2001042273A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/14/2001 | WO2001042252A1 New aminopropylphosphinic acids |
| 06/14/2001 | WO2001042246A2 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS |
| 06/14/2001 | WO2001042241A1 Substituted pyridazines having cytokine inhibitory activity |
| 06/14/2001 | WO2001042231A2 Polyhydroxystilbenes and stilbene oxides as antisoriatic agents and protein kinase inhibitors |
| 06/14/2001 | WO2001042225A2 4-pyrimidinyl-n-acyl-l-phenylalanines |
| 06/14/2001 | WO2001042222A1 Polymorphic crystalline forms of celecoxib |
| 06/14/2001 | WO2001042221A1 Solid-state form of celecoxib having enhanced bioavailability |